Literature DB >> 11371668

Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits.

T Avcin1, A Ambrozic, M Kuhar, T Kveder, B Rozman.   

Abstract

OBJECTIVES: To determine anticardiolipin (aCL) and anti-beta(2) glycoprotein I antibodies (anti-beta(2)GPI) in apparently healthy children and express the cut-off levels in concentrations of monoclonal antibodies, and to compare the mean values and frequencies of aCL and anti-beta(2)GPI in children with those in blood donors.
METHODS: Blood samples were collected from 29 preschool children and 32 adolescents during their routine preventive follow-up visits. The control group consisted of 52 blood donors. aCL and anti-beta(2)GPI were assayed by an ELISA method. Two monoclonal beta(2)GPI-dependent aCL (HCAL and EY2C9) were used as calibrators.
RESULTS: The estimated cut-off values for immunoglobulin G (IgG) and immunoglobulin M (IgM) aCL, expressed in concentrations of monoclonal antibodies and standardized international units (GPL/MPL units), were 13.9 ng/ml (7.6 GPL) and 33.1 ng/ml (3.3 MPL) for preschool children, 13.5 ng/ml (7.2 GPL) and 36.9 ng/ml (4.0 MPL) for adolescents, and 14.4 ng/ml (8.0 GPL) and 42.6 ng/ml (5.1 MPL) for blood donors. No statistically significant differences in the mean values for IgG and IgM aCL were found between the age groups. The mean value of IgA aCL was significantly higher in blood donors than in preschool children and adolescents (P<0.037 and P<0.025 respectively). Seven (11.4%) of 61 apparently healthy children had low positive values for aCL (IgG for all seven). The estimated cut-off values for IgG and IgM anti-beta(2)GPI were 4.2 and 13.1 ng/ml respectively for preschool children, 3.2 and 13.1 ng/ml for adolescents, and 2.9 and 20.5 ng/ml for blood donors. The mean value for IgG anti-beta(2)GPI was found to be higher in preschool children than in adolescents and blood donors (P<0.0001 and P<0.0001). The mean values for IgM and IgA anti-beta(2)GPI were higher in blood donors than in preschool children (IgM, P<0.007; IgA, P<0.0001) and adolescents (IgM, P<0.01; IgA, P<0.0001). Four (6.6%) of 61 apparently healthy children had positive values for anti-beta(2)GPI (two for IgG and two for IgA).
CONCLUSIONS: This is the first report in which the cut-off values for aCL and anti-beta(2)GPI in children are expressed in concentrations of monoclonal antibodies. Low titres of aCL, which were identified frequently in apparently healthy children, were hypothesized to be the result of previous infections. The high mean value of IgG anti-beta(2)GPI observed in preschool children was an unexpected result of the study and might indicate a default response to nutritional exposure to beta(2)GPI in this age group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371668     DOI: 10.1093/rheumatology/40.5.565

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  Clinical and laboratory characteristics of children positive for antiphospholipid antibodies.

Authors:  Paola Giordano; Riccardina Tesse; Giuseppe Lassandro; Deborah Fracchiolla; Prudenza Ranieri; Antonella Lotito; Domenico De Mattia; Giovanni Carlo Del Vecchio
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

Review 3.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

4.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

Review 5.  Update on antiphospholipid syndrome in children.

Authors:  Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

6.  Antı-β2 Glycoprotein I Antibodies in Children with Rheumatologic Disorders.

Authors:  Elif Azarsiz; Gamze Eman; Sanem Eren Akarcan; Ezgi Ulusoy Severcan; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Indian J Clin Biochem       Date:  2017-11-10

7.  Infant stroke and beta-2-glycoprotein 1 antibodies: six cases.

Authors:  Freja Ebeling; Jari Petäjä; Soile Alanko; Aune Hirvasniemi; Tarja Holm; Marja Lähde; Auli Nuutila; Helena Pesonen; Elina Vahtera; Vesa Rasi
Journal:  Eur J Pediatr       Date:  2003-08-12       Impact factor: 3.183

8.  Mania: psychiatric manifestations of the antiphospholipid syndrome.

Authors:  Haniya Raza; Steven A Epstein; Maryland Pao; Donald L Rosenstein
Journal:  Psychosomatics       Date:  2008 Sep-Oct       Impact factor: 2.386

9.  Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea.

Authors:  Patrícia C Faustino; Maria Teresa R A Terreri; Antônio J da Rocha; Marcelo C Zappitelli; Henrique M Lederman; Maria Odete E Hilário
Journal:  Neuroradiology       Date:  2003-06-17       Impact factor: 2.804

Review 10.  Antiphospholipid antibodies in pediatrics.

Authors:  Ana I Quintero-Del-Rio
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.